PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1859817
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1859817
According to Stratistics MRC, the Global Pet Nutrition for Cognitive Health Market is accounted for $1.3 billion in 2025 and is expected to reach $2.3 billion by 2032 growing at a CAGR of 8.8% during the forecast period. Pet nutrition for cognitive health refers to the strategic use of diet and supplements to support brain function, reduce age-related decline, and enhance mental well-being in pets. As animals age, they may experience cognitive dysfunction, similar to dementia in humans. Nutritional interventions-such as omega-3 fatty acids, antioxidants, B vitamins, and medium-chain triglycerides-can help preserve memory, learning, and behavior. Probiotics and polyphenols also show promise in reducing anxiety and improving mood. Tailored diets not only nourish the body but also protect neural pathways, making nutrition a vital tool in maintaining alertness, emotional stability, and quality of life for aging pets.
Rising Pet Humanization
The rising trend of pet humanization is significantly fueling growth in the Pet Nutrition for Cognitive Health Market. As pet owners increasingly treat their pets as family members, there is a stronger demand for premium, science-backed nutrition that supports cognitive function and overall well-being. This shift encourages innovation in nutraceutical formulations, functional ingredients, and specialized diets. Consequently, companies are investing in research and marketing to cater to health-conscious pet owners, driving market expansion and creating opportunities for advanced cognitive health-focused pet foods.
Limited Clinical Validation
Limited clinical validation in the Pet Nutrition for Cognitive Health market significantly hampers growth by undermining consumer trust and professional endorsement. Pet owners and veterinarians may hesitate to adopt products without robust scientific evidence, perceiving them as unreliable or ineffective. This lack of validated research slows market acceptance, discourages investment in innovation, and reduces overall demand, creating a challenging environment for manufacturers striving to establish credibility and expand their market presence.
Innovation in Nutraceuticals
The surge of innovation in nutraceuticals is profoundly driving the Pet Nutrition for Cognitive Health Market. Advanced formulations, enriched with antioxidants, omega fatty acids, and bioactive compounds, are enhancing pets' cognitive function and overall well-being. Continuous research and product development are introducing targeted, science-backed solutions, boosting consumer confidence and adoption. This wave of innovation not only expands market offerings but also accelerates growth, positioning the sector as a forefront of pet health advancement.
High Cost of Premium Supplements
The high cost of premium supplements poses a significant barrier in the Pet Nutrition for Cognitive Health market. Many pet owners are unable or unwilling to invest in costly cognitive health products, limiting widespread adoption. This price sensitivity slows market growth, discourages innovation, and constrains smaller companies from entering the sector. As a result, the accessibility of advanced nutritional solutions remains restricted, hindering overall market expansion and consumer reach.
Covid-19 Impact
The COVID-19 pandemic significantly reshaped the market. With increased pet adoption and deeper emotional bonds formed during lockdowns, demand surged for brain-supportive diets and supplements. Consumers prioritized mental well-being for aging pets, driving growth in omega-3s, vitamins, and mood-enhancing formulations. E-commerce expansion and heightened awareness of preventive care accelerated market penetration, despite initial supply chain disruptions and manufacturing slowdowns across key regions.
The omega-3 fatty acids segment is expected to be the largest during the forecast period
The omega-3 fatty acids segment is expected to account for the largest market share during the forecast period, due to its well-established role in supporting neural integrity and reducing inflammation. These essential fatty acids, particularly DHA and EPA, are clinically linked to improved memory, learning capacity, and behavioral stability in aging pets. Their widespread inclusion in premium pet diets and supplements, coupled with rising consumer awareness of brain health, positions omega-3s as the cornerstone of cognitive-focused formulations across both therapeutic and preventive applications.
The vitamins segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the vitamins segment is predicted to witness the highest growth rate, due to growing demand for targeted micronutrients. B-complex vitamins, in particular, play a critical role in neurotransmitter synthesis and energy metabolism, directly influencing cognitive performance and emotional regulation. As pet owners increasingly seek holistic interventions, vitamin-enriched formulations are gaining traction for their affordability, accessibility, and compatibility with daily feeding routines. This surge reflects a broader shift toward functional nutrition and proactive mental wellness strategies in companion animals.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising pet ownership and growing disposable incomes across key economies such as China, Japan, and India. The region's expanding middle class is driving demand for premium pet care products, including cognitive-enhancing diets and supplements. Cultural shifts toward pet humanization and increased veterinary awareness are further accelerating adoption. Local manufacturers are also innovating with region-specific ingredients and formats, making Asia Pacific a dynamic hub for market expansion and product diversification.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strong consumer inclination toward preventive wellness. The region benefits from robust R&D in pet nutraceuticals, with frequent product launches targeting cognitive decline in senior pets. Rising awareness of conditions like Canine Cognitive Dysfunction (CCD) and the influence of pet insurance coverage are encouraging early adoption of brain-supportive nutrition. Additionally, e-commerce penetration and personalized supplement offerings are reshaping purchasing behavior, driving sustained growth across the U.S. and Canada.
Key players in the market
Some of the key players profiled in the Pet Nutrition for Cognitive Health Market include Mars Petcare, Affinity Petcare S.A., Nestle Purina PetCare, PetIQ Inc., Hill's Pet Nutrition, FoodScience Corporation, Royal Canin, Zesty Paws, Zoetis, Nutramax Laboratories, Elanco Animal Health, Kemin Industries, Virbac, Ceva Sante Animale and Bayer Animal Health.
In June 2025, Mars Petcare, in collaboration with Big Idea Ventures, launched the 2025 Global Next Generation Pet Food Program. This initiative aims to accelerate sustainable innovation in the pet food sector by supporting startups with novel ingredients, sustainable fats and proteins, and advanced processing technologies.
In March 2025, Elanco signed a research agreement with WEDterinary LLC, co-founded by William Doyle, to explore novel therapies for chronic kidney disease in cats and investigate approaches to extend the healthy lifespan of pets. The collaboration aims to leverage gene therapy and AI technologies to advance pet healthcare.